Hearing loss accelerates cognitive decline in older adults

February, 2013

A large study finds that hearing loss significantly increases the rate of cognitive decline in old age.

I’ve written before about the gathering evidence that sensory impairment, visual impairment and hearing loss in particular, is a risk factor for age-related cognitive decline and dementia. Now a large long-running study provides more support for the association between hearing loss and age-related cognitive decline.

The study involved 1,984 older adults (aged 75-84) whose hearing and cognition was tested at the start of the study, with cognitive performance again assessed three, five, and six years later.

Those with hearing loss showed significantly faster cognitive decline than those with normal hearing — some 30-40% faster (41% on the MMSE; 32% on the Digit Symbol Substitution Test), with rate directly related to the amount of hearing loss.

On average, older adults with hearing loss developed significant cognitive impairment 3.2 years sooner than those with normal hearing — a very significant difference indeed.

It has been suggested that increasing social isolation and loneliness may underlie some, if not all, of this association. It may also be that difficulties in hearing force the brain to devote too much of its resources to processing sound, leaving less for cognition. A third possibility is that some common factor underlies both hearing loss and cognitive decline — however, the obvious risk factors, such as high blood pressure, diabetes and stroke, were taken account of in the analysis.

The findings emphasize the importance of getting help for hearing difficulties, rather than regarding them as ‘natural’ in old age.

Reference: 

[3293] Lin, F. R., Yaffe K., Xia J., & et al
(2013).  Hearing loss and cognitive decline in older adults.
JAMA Internal Medicine. 1 - 7.

Related News

It’s been suggested before that Down syndrome and Alzheimer's are connected. Similarly, there has been evidence for connections between diabetes and Alzheimer’s, and cardiovascular disease and Alzheimer’s. Now new evidence shows that all of these share a common disease mechanism.

Part of the Women's Health Initiative study looking at the effect of hormone therapy on thinking and memory in postmenopausal women, involving over 1400 women, has found those who had high blood pressure at the start of the study (eight years earlier) had significantly higher amounts of

A three-year study involving 169 people with mild cognitive impairment has found that those who later developed Alzheimer's disease showed 10-30% greater atrophy in two specific locations within the

A study involving 511 older adults (average age 78) has found that 11.6% of those with very mild or mild Alzheimer’s (43% of the participants) had mental lapses, compared to only 2 of the 295 without Alzheimer’s. Those with mental lapses also tended to have more severe Alzheimer’s.

Loss of memory and problems with judgment in dementia patients can cause difficulties in relation to eating and nutrition; these problems in turn can lead to poor quality of life, pressure ulcers and infections.

A European trial involving 225 patients with mild Alzheimer's has found that those who drank Souvenaid (a cocktail of uridine, choline and the omega-3 fatty acid DHA, plus B vitamins, phosopholipids and antioxidants) for 12 weeks were more likely to improve their performance in a delayed verbal

Subjective cognitive impairment (SCI), marked by situations such as when a person recognizes they can't remember a name like they used to or where they recently placed important objects the way they used to, is experienced by between one-quarter and one-half of the population over the age of 65.

A German study involving nearly 4000 older adults (55+) has found that physical activity significantly reduced the risk of developing mild cognitive impairment over a two-year period.

Rodent studies have demonstrated the existence of specialized neurons involved in spatial memory.

Although HIV doesn't directly infect neurons, it appears that once it has crossed the blood-brain barrier, it affects supporting cells that can release immune factors that harm neurons.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news
Error | About memory

Error

The website encountered an unexpected error. Please try again later.